Annual Cash & Cash Equivalents
$41.87 M
-$19.46 M-31.73%
December 31, 2023
Summary
- As of February 22, 2025, FATE annual cash & cash equivalents is $41.87 million, with the most recent change of -$19.46 million (-31.73%) on December 31, 2023.
- During the last 3 years, FATE annual cash & cash equivalents has fallen by -$125.48 million (-74.98%).
- FATE annual cash & cash equivalents is now -78.02% below its all-time high of $190.51 million, reached on December 31, 2018.
Performance
FATE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$37.91 M
+$992.00 K+2.69%
September 30, 2024
Summary
- As of February 22, 2025, FATE quarterly cash and cash equivalents is $37.91 million, with the most recent change of +$992.00 thousand (+2.69%) on September 30, 2024.
- Over the past year, FATE quarterly cash and cash equivalents has increased by +$4.58 million (+13.72%).
- FATE quarterly cash and cash equivalents is now -91.25% below its all-time high of $433.07 million, reached on June 30, 2020.
Performance
FATE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FATE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.7% | +13.7% |
| 3 y3 years | -75.0% | -9.8% |
| 5 y5 years | -78.0% | -54.5% |
FATE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.7% | at low | -71.6% | +13.7% |
| 5 y | 5-year | -75.0% | at low | -91.3% | +13.7% |
| alltime | all time | -78.0% | +555.5% | -91.3% | +1015.3% |
Fate Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $37.91 M(+2.7%) |
| Jun 2024 | - | $36.92 M(-69.6%) |
| Mar 2024 | - | $121.32 M(+189.8%) |
| Dec 2023 | $41.87 M(-31.7%) | $41.87 M(+25.6%) |
| Sep 2023 | - | $33.33 M(-28.8%) |
| Jun 2023 | - | $46.80 M(+11.4%) |
| Mar 2023 | - | $42.02 M(-31.5%) |
| Dec 2022 | $61.33 M(-54.1%) | $61.33 M(-25.3%) |
| Sep 2022 | - | $82.09 M(+48.5%) |
| Jun 2022 | - | $55.27 M(-14.6%) |
| Mar 2022 | - | $64.74 M(-51.5%) |
| Dec 2021 | $133.58 M(-20.2%) | $133.58 M(+3.4%) |
| Sep 2021 | - | $129.18 M(+68.5%) |
| Jun 2021 | - | $76.65 M(-28.0%) |
| Mar 2021 | - | $106.41 M(-36.4%) |
| Dec 2020 | $167.35 M(+67.7%) | $167.35 M(-52.1%) |
| Sep 2020 | - | $349.13 M(-19.4%) |
| Jun 2020 | - | $433.07 M(+419.5%) |
| Mar 2020 | - | $83.37 M(-16.5%) |
| Dec 2019 | $99.81 M(-47.6%) | $99.81 M(-60.0%) |
| Sep 2019 | - | $249.59 M(+249.4%) |
| Jun 2019 | - | $71.44 M(-61.0%) |
| Mar 2019 | - | $183.03 M(-3.9%) |
| Dec 2018 | $190.51 M | $190.51 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $183.25 M(+406.7%) |
| Jun 2018 | - | $36.16 M(+9.9%) |
| Mar 2018 | - | $32.91 M(-63.0%) |
| Dec 2017 | $88.95 M(+0.4%) | $88.95 M(+105.8%) |
| Sep 2017 | - | $43.23 M(+39.2%) |
| Jun 2017 | - | $31.06 M(-23.5%) |
| Mar 2017 | - | $40.61 M(-54.2%) |
| Dec 2016 | $88.61 M(+36.7%) | $88.61 M(+138.8%) |
| Sep 2016 | - | $37.10 M(+3.4%) |
| Jun 2016 | - | $35.87 M(-9.2%) |
| Mar 2016 | - | $39.49 M(-39.1%) |
| Dec 2015 | $64.81 M(+32.0%) | $64.81 M(-11.0%) |
| Sep 2015 | - | $72.86 M(-10.2%) |
| Jun 2015 | - | $81.18 M(+91.7%) |
| Mar 2015 | - | $42.35 M(-13.8%) |
| Dec 2014 | $49.10 M(-9.1%) | $49.10 M(+7.8%) |
| Sep 2014 | - | $45.53 M(+8.4%) |
| Jun 2014 | - | $42.01 M(-12.3%) |
| Mar 2014 | - | $47.88 M(-11.4%) |
| Dec 2013 | $54.04 M(+494.7%) | $54.04 M(+183.2%) |
| Sep 2013 | - | $19.08 M(+461.4%) |
| Jun 2013 | - | $3.40 M(-62.6%) |
| Dec 2012 | $9.09 M(+42.3%) | $9.09 M |
| Dec 2011 | $6.39 M | - |
FAQ
- What is Fate Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Fate Therapeutics?
- What is Fate Therapeutics annual cash & cash equivalents year-on-year change?
- What is Fate Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Fate Therapeutics?
- What is Fate Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Fate Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of FATE is $41.87 M
What is the all time high annual cash & cash equivalents for Fate Therapeutics?
Fate Therapeutics all-time high annual cash & cash equivalents is $190.51 M
What is Fate Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, FATE annual cash & cash equivalents has changed by -$19.46 M (-31.73%)
What is Fate Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FATE is $37.91 M
What is the all time high quarterly cash and cash equivalents for Fate Therapeutics?
Fate Therapeutics all-time high quarterly cash and cash equivalents is $433.07 M
What is Fate Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, FATE quarterly cash and cash equivalents has changed by +$4.58 M (+13.72%)